Biotech: Jean-Paul Clozel kämpft bei Idorsia mit Gegenwind
Qui est Jean-Paul Clozel ?
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Jean-Paul Clozel
Actelion — Wikipédia
Martine et Jean-Paul Clozel, le couple vedette de la pharmacie mondiale
Jean-Paul Clozel
Jean-Paul Clozel, CEO d'Actelion - rts.ch - Portail Audio
Actelion: Die Knackpunkte eines Deals mit Johnson & Johnson | Der Bund
Actelion — Wikipédia
How is Actelion Spin-Off Idorsia Doing One Year Later?
CAPTION ADDITION---Jean-Paul Clozel, CEO of biopharmaceutical company Actelion, speaks during a press conference in Allschwil, Switzerland, Thursday, February 22, 2007. Actelion announced its financial results for the full year 2006. With total
Jean-Paul Clozel, CEO Actelion - YouTube
Molecular Millionaire: Jean-Paul Clozel of Actelion
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Avec Idorsia, Jean-Paul Clozel a déjà atteint son premier but - Le Temps
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
Fondateurs d'Actelion: Le couple à succès de la pharma suisse lutte pour son héritage | 24 heures
Social. Fleuron de la biopharma bâloise, Idorsia licencie en masse
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
15 photos et images de Actelion Ltd News Conference As Drugmaker Agrees 30 Takeover Billion With Johnson Johnson - Getty Images
